Panton-Valentine leukocidin-positive novel sequence type 5959 community-acquired methicillin-resistant Staphylococcus aureus meningitis complicated by cerebral infarction in a 1-month-old infant

J Infect Chemother. 2021 Jan;27(1):103-106. doi: 10.1016/j.jiac.2020.09.011. Epub 2020 Sep 26.

Abstract

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has become a pathogen of major importance in pediatric patients. CA-MRSA can cause skin and soft tissue infection in children and young active adults with no predisposing factors, and life-threatening infections such as meningitis or necrotizing pneumonia have been reported. We report here a case of CA-MRSA meningitis complicated by acute left middle cerebral artery (MCA) infarction and necrotizing pneumonia in a previously healthy 1-month-old Vietnamese boy. He was firstly treated with vancomycin, but changed to linezolid because of persistent fever and low vancomycin trough level. He recovered successfully with residual right-sided hemiparesis. The mode of transmission of CA-MRSA and the mechanism of cerebral infarction (thrombotic or embolic) were unknown. The isolate was genotyped as staphylococcal cassette chromosome (SCC) mec type V with a novel sequence type (ST) 5959 harboring the Panton-Valentine leukocidin (PVL) gene. ST 5959 is a double locus variant of ST 59, which is a major PVL-positive CA-MRSA strain isolated in invasive disease in Asian countries. This case report may serve as a warning about the dissemination of PVL-positive CA-MRSA in and around Japan, with the possibility of causing serious life-threatening disease. The potential of linezolid for the treatment of MRSA meningitis as one of the alternative MRSA therapeutic drugs is also discussed.

Keywords: Infant; Meningitis; Methicillin-resistant Staphylococcus aureus; Panton-Valentine leukocidin.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Asia
  • Bacterial Toxins
  • Cerebral Infarction / complications
  • Cerebral Infarction / drug therapy
  • Child
  • Community-Acquired Infections* / drug therapy
  • Exotoxins / genetics
  • Humans
  • Infant
  • Japan
  • Leukocidins / genetics
  • Male
  • Meningitis*
  • Methicillin-Resistant Staphylococcus aureus* / genetics
  • Staphylococcal Infections* / complications
  • Staphylococcal Infections* / drug therapy

Substances

  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin